Table 2 Crude and age-adjusted prevalence of CAD by age group and gender

20–29

144

2.78

1.37

192

7.29

1.88

−4.51

(−9.07,0.04)

0.069

30–39

306

6.54

1.42

582

8.93

1.18

−2.40

(−6.01,1.21)

0.213

40–49

465

7.10

1.19

734

14.44

1.30

−7.34

(−10.80,−3.89)

<0.001

50–59

386

12.44

1.68

638

19.91

1.58

−7.47

(−11.99,−2.95)

0.002

60–69

537

22.72

1.81

679

25.77

1.68

−3.05

(−7.89,1.78)

0.218

70–79

234

32.05

3.06

270

29.26

2.77

2.79

(−5.28,10.87)

0.497

All

2072

14.58

0.78

3095

17.87

0.69

−3.29

(−5.32,−1.26)

0.002

Age adjusted

2072

9.80

0.65

3095

14.26

0.69

−4.46

(−6.24,−2.69)

<0.001

Definite CAD

20–29

144

0.00

0.00

192

0.00

0.00

-

-

-

30–39

306

2.29

0.86

582

0.52

0.30

1.77

(0.00,3.55)

0.017

40–49

465

3.87

0.90

734

1.77

0.49

2.10

(0.10,4.10)

0.026

50–59

386

6.48

1.25

638

3.13

0.69

3.34

(0.54,6.14)

0.012

60–69

537

13.41

1.47

679

8.98

1.10

4.42

(0.83,8.02)

0.014

70–79

234

18.80

2.56

270

12.59

2.02

6.21

(−0.17,12.59)

0.055

All

2072

8.01

0.60

3095

4.23

0.36

3.78

(2.41,5.15)

<0.001

Age adjusted

2072

4.80

0.39

3095

2.63

0.23

2.17

(1.09,3.25)

<0.001